Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery

Abdominal obesity is associated with hypertension, increased fasting glucose, HbA1c, and cholesterol. Body mass index (BMI) is frequently used to measure and define obesity and as inclusion criteria for bariatric surgery. Sagittal abdominal diameter (SAD) has been suggested to predict the amount of...

Full description

Saved in:
Bibliographic Details
Main Authors: Erica Aldenbäck, Hans-Erik Johansson
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Obesity
Online Access:http://dx.doi.org/10.1155/2021/6647328
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849397835896717312
author Erica Aldenbäck
Hans-Erik Johansson
author_facet Erica Aldenbäck
Hans-Erik Johansson
author_sort Erica Aldenbäck
collection DOAJ
description Abdominal obesity is associated with hypertension, increased fasting glucose, HbA1c, and cholesterol. Body mass index (BMI) is frequently used to measure and define obesity and as inclusion criteria for bariatric surgery. Sagittal abdominal diameter (SAD) has been suggested to predict the amount of visceral fat, metabolic traits, and cardiometabolic risk superior to BMI. The aim was to test whether SAD has stronger correlations to glucometabolic traits compared to BMI. One hundred and fifty-five (108 women, 47 men) morbidly obese patients undergoing bariatric surgery were evaluated before (baseline), 6 and 12 months after Roux-en-Y gastric bypass (RYGBP). BMI was reduced from 43.7 kg/m2 (baseline) to 31.3 kg/m2 (12 months) and SAD from 32.6 to 23.2 cm (both p<0.001). SAD correlated with CRP (p=0.04), fasting glucose (p=0.008), HbA1c (p=0.016), triglycerides (p=0.017), systolic blood pressure (p=0.032), and vitamin D (p=0.027). BMI correlated with CRP (p=0.006), triglycerides (p=0.016), vitamin D (p=0.002), and magnesium (p=0.037). Despite RYGBP surgery, vitamin D was significantly increased. Liver enzymes were significantly lowered after RYGBP and the change over time in SAD correlated with gamma-glutamyltransferase. SAD was superior to BMI to predict glucose disturbance and dyslipidemia implying increased use of SAD as it is cost effective and simple to perform in the clinic and could be of value when considering patients for bariatric surgery.
format Article
id doaj-art-a7df7707320143d092694647fdfe4ae2
institution Kabale University
issn 2090-0708
2090-0716
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Obesity
spelling doaj-art-a7df7707320143d092694647fdfe4ae22025-08-20T03:38:49ZengWileyJournal of Obesity2090-07082090-07162021-01-01202110.1155/2021/66473286647328Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass SurgeryErica Aldenbäck0Hans-Erik Johansson1Bariatric Clinic, Department of Surgery, Falun Hospital, Falun, SwedenBariatric Clinic, Department of Surgery, Falun Hospital, Falun, SwedenAbdominal obesity is associated with hypertension, increased fasting glucose, HbA1c, and cholesterol. Body mass index (BMI) is frequently used to measure and define obesity and as inclusion criteria for bariatric surgery. Sagittal abdominal diameter (SAD) has been suggested to predict the amount of visceral fat, metabolic traits, and cardiometabolic risk superior to BMI. The aim was to test whether SAD has stronger correlations to glucometabolic traits compared to BMI. One hundred and fifty-five (108 women, 47 men) morbidly obese patients undergoing bariatric surgery were evaluated before (baseline), 6 and 12 months after Roux-en-Y gastric bypass (RYGBP). BMI was reduced from 43.7 kg/m2 (baseline) to 31.3 kg/m2 (12 months) and SAD from 32.6 to 23.2 cm (both p<0.001). SAD correlated with CRP (p=0.04), fasting glucose (p=0.008), HbA1c (p=0.016), triglycerides (p=0.017), systolic blood pressure (p=0.032), and vitamin D (p=0.027). BMI correlated with CRP (p=0.006), triglycerides (p=0.016), vitamin D (p=0.002), and magnesium (p=0.037). Despite RYGBP surgery, vitamin D was significantly increased. Liver enzymes were significantly lowered after RYGBP and the change over time in SAD correlated with gamma-glutamyltransferase. SAD was superior to BMI to predict glucose disturbance and dyslipidemia implying increased use of SAD as it is cost effective and simple to perform in the clinic and could be of value when considering patients for bariatric surgery.http://dx.doi.org/10.1155/2021/6647328
spellingShingle Erica Aldenbäck
Hans-Erik Johansson
Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery
Journal of Obesity
title Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery
title_full Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery
title_fullStr Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery
title_full_unstemmed Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery
title_short Anthropometric Measurements and Correlations to Glucometabolic and Cardiovascular Risk in Obese Patients Undergoing Gastric Bypass Surgery
title_sort anthropometric measurements and correlations to glucometabolic and cardiovascular risk in obese patients undergoing gastric bypass surgery
url http://dx.doi.org/10.1155/2021/6647328
work_keys_str_mv AT ericaaldenback anthropometricmeasurementsandcorrelationstoglucometabolicandcardiovascularriskinobesepatientsundergoinggastricbypasssurgery
AT hanserikjohansson anthropometricmeasurementsandcorrelationstoglucometabolicandcardiovascularriskinobesepatientsundergoinggastricbypasssurgery